Staar Surgical reports Q2 EPS (34c), consensus (56c)

Reports Q2 revenue 44.3M, consensus $40.92M. The company said, “The year-over-year decrease was mainly driven by a notable decline in revenue from China, as the Company’s distributors in the region made minimal purchases during the quarter, opting to utilize existing in-country inventory to meet procedural demand. This decline was partially offset by growth in other regions. Excluding China, net sales were $39.0 million, an increase of 10% as compared to the prior-year period.”